Antitumor activity of iRGD-modified red blood cell membrane nanoparticles loaded with Juglone and Oxaliplatin against colorectal cancer
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Biomaterials Applications"
DOI: 10.1177/08853282211052386
Abstract: Poor solubility and non-specific biological distribution are critical obstacles for applying Juglone (Jug) into clinical practice. To improve the antitumor efficacy of Jug, an iRGDmodified red blood cell membrane (RBCm) platform was developed to package… read more here.
Keywords: jug; jug oxa; cell; irgd ... See more keywords